Palatin Technologies competitorsClear all

Palatin Technologies's top competitors include Acticor Biotech and GBT (Global Blood Therapeutics).
Palatin Technologies
Palatin Technologies
Palatin Technologies is a biopharmaceutical company, developing targeted, receptor-specific peptide therapeutics for the treatment of various diseases.
Acticor Biotech
Acticor Biotech
Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics)
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
Founding Date
Founding Date
1986
Founding Date
2013
Founding Date
2012
Type
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
East Windsor, US HQ
Locations
Paris, FR HQ
Paris, FR
Locations
South San Francisco, US HQ
Employees
Employees
185% decrease
Employees
2011% increase
Employees
352106% increase
Valuation ($)
Valuation ($)
100 m
Valuation ($)
N/A
Valuation ($)
2.7 b
Twitter followers
Twitter followers
533
Twitter followers
331
Twitter followers
1.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Number of tweets (last 30 days)
43
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
1.8
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
69.77%
Alexa Website Rank
Alexa Website Rank
307211
Alexa Website Rank
257693
Alexa Website Rank
488148
Employee Rating
Employee Rating
4
Employee Rating
N/A
Employee Rating
4.8

Financial

Revenue (est.)
Revenue (est.)
$60.3m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$2.1m (FY, 2019)
Net income
Net income
$35.8m (FY, 2019)
Net income
N/A
Net income
($266.8m) (FY, 2019)

Funding

Total funding raised
Total funding raised
$ 104.2m
Total funding raised
$ 33.3m
Total funding raised
$ 88.7m
For sources of this data, please see the company profile

View company profiles

Acticor Biotech
HQ
Paris, FR
Employees
20↑ 11% increase

Acticor Biotech is a biopharmaceutical company developing an antithrombotic agent for the treatment of the acute phase of ischemic stroke.

View company
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352

GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.

View company